• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13D filed by Ashland Inc.

    12/1/25 8:30:08 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary
    Get the next $ASH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    ASHLAND INC.

    (Name of Issuer)


    Common Stock, par value $0.01 per share

    (Title of Class of Securities)


    044186104

    (CUSIP Number)


    David S. Winter
    Standard Investments LLC, 9 West 57th Street, 47th Floor
    New York, NY, 10019
    (212) 821-1600


    David J. Millstone
    Standard Investments LLC, 9 West 57th Street, 47th Floor
    New York, NY, 10019
    (212) 821-1600


    Kyle A. Harris, Esq.
    Cleary Gottlieb Steen & Hamilton LLP, One Liberty Plaza
    New York, NY, 10006
    (212) 225-2000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    11/21/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    044186104


    1 Name of reporting person

    Standard Investments LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,625,000.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,625,000.00
    11Aggregate amount beneficially owned by each reporting person

    2,625,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.7 %
    14Type of Reporting Person (See Instructions)

    IA, OO



    SCHEDULE 13D

    CUSIP No.
    044186104


    1 Name of reporting person

    SI GP III LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,625,000.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,625,000.00
    11Aggregate amount beneficially owned by each reporting person

    2,625,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.7 %
    14Type of Reporting Person (See Instructions)

    OO



    SCHEDULE 13D

    CUSIP No.
    044186104


    1 Name of reporting person

    Standard Latitude Master Fund Ltd.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,625,000.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,625,000.00
    11Aggregate amount beneficially owned by each reporting person

    2,625,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.7 %
    14Type of Reporting Person (See Instructions)

    CO



    SCHEDULE 13D

    CUSIP No.
    044186104


    1 Name of reporting person

    Standard Latitude Fund LP
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,625,000.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,625,000.00
    11Aggregate amount beneficially owned by each reporting person

    2,625,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.7 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    044186104


    1 Name of reporting person

    David S. Winter
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,625,000.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,625,000.00
    11Aggregate amount beneficially owned by each reporting person

    2,625,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.7 %
    14Type of Reporting Person (See Instructions)

    IN



    SCHEDULE 13D

    CUSIP No.
    044186104


    1 Name of reporting person

    David J. Millstone
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    2,625,000.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    2,625,000.00
    11Aggregate amount beneficially owned by each reporting person

    2,625,000.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.7 %
    14Type of Reporting Person (See Instructions)

    IN



    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, par value $0.01 per share
    (b)Name of Issuer:

    ASHLAND INC.
    (c)Address of Issuer's Principal Executive Offices:

    8145 Blazer Drive, Wilmington, DELAWARE , 19808.
    Item 2.Identity and Background
    (a)
    This statement (the "Schedule 13D") is being filed by (i) Standard Investments LLC, a Delaware limited liability company ("Standard Investments"), (ii) Standard Latitude Fund LP, a Delaware limited partnership ("Standard Latitude Feeder"), (iii) SI GP III LLC, a Delaware limited liability company ("SI GP III"), (iv) Standard Latitude Master Fund Ltd., a Cayman Islands exempted company incorporated with limited liability ("Standard Latitude Master"), (v) David S. Winter, a managing member of Standard Investments ("Mr. Winter") and (vi) David J. Millstone, a managing member of Standard Investments ("Mr. Millstone"), with respect to the shares of common stock, par value $0.01 per share (the "Shares"), of Ashland Inc. (the "Issuer") held by Standard Latitude Master. Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." Each of the Reporting Persons is party to that certain Joint Filing Agreement attached hereto as Exhibit 99.1 and incorporated by reference herein. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.
    (b)
    The business address of each of the Reporting Persons is 9 West 57th Street, 47th Floor, New York, New York 10019.
    (c)
    The principal business of each of Standard Latitude Feeder and Standard Latitude Master is the making of investments in securities and other assets. The principal business of SI GP III is to serve as general partner of Standard Latitude Feeder. Standard Investments serves as principal investment manager to Standard Latitude Feeder and Standard Latitude Master. As such, Standard Investments has been granted investment discretion over portfolio investments, including the Shares. Messrs. Winter and Millstone serve as the managing members and principals of each of Standard Investments and SI GP III, and as the sole directors of Standard Latitude Master.
    (d)
    During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
    (e)
    During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
    (f)
    See Item 2(a). Messrs. Winter and Millstone are citizens of the United States of America.
    Item 3.Source and Amount of Funds or Other Consideration
     
    The Shares reported herein were purchased by Standard Latitude Master using its working capital in open market purchases, except as otherwise noted. The total purchase price for the Shares reported herein was $133,023,241, including brokerage commissions. All or part of the Shares owned by the Reporting Persons may from time to time be pledged with one or more banking institutions or brokerage firms as collateral for loans made by such bank(s) or brokerage firm(s) to the Reporting Persons. Such indebtedness may be refinanced with other banks or broker dealers.
    Item 4.Purpose of Transaction
     
    The Reporting Persons acquired the Shares to which this Schedule 13D relates because they believe the Shares represent an attractive investment opportunity. The Reporting Persons and their representatives have, from time to time, engaged in, and expect to continue to engage in, discussions with members of management of the Issuer and the board of directors of the Issuer (the "Board"), other current or prospective shareholders, industry analysts, existing or potential strategic partners and other third parties regarding a variety of matters relating to the Issuer, which may include, among other things, the Issuer's business, management, capital structure and allocation, corporate governance, Board composition and strategic alternatives and direction, and may take other steps seeking to bring about changes to increase shareholder value as well as pursue other plans or proposals that relate to or could result in any of the matters set forth in clauses (a)-(j) of Item 4 of Schedule 13D. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions referenced above, the Issuer's financial position, results and strategic direction, actions taken by the Issuer's management and the Board, price levels of the Shares, other investment opportunities available to the Reporting Persons, conditions in the securities and other markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, exchanging information with the Issuer or other third parties pursuant to appropriate confidentiality or similar agreements, proposing changes in the Issuer's operations, governance or capitalization, acquiring additional Shares and/or other equity, debt, notes, instruments or other securities of the Issuer (collectively, "Securities") or disposing of some or all of the Securities beneficially owned by them, in public market or privately negotiated transactions, entering into financial instruments or other agreements that increase or decrease the Reporting Persons' economic exposure with respect to their investment in the Issuer and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D.
    Item 5.Interest in Securities of the Issuer
    (a)
    See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Shares and percentage of the Shares beneficially owned by each of the Reporting Persons. The aggregate percentage of Shares reported beneficially owned by each of the Reporting Persons is based upon 45,718,113 Shares outstanding, as of October 31, 2025, as reported in the Issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 20, 2025. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.
    (b)
    See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and the sole or shared power to dispose or to direct the disposition.
    (c)
    Information concerning transactions in the Shares effected by the Reporting Persons during the past sixty (60) days is set forth in Schedule 1 attached hereto and is incorporated herein by reference. Except as otherwise noted, all of the transactions in the Shares listed therein were effected in the open market through various brokerage entities.
    (d)
    No persons other than the Reporting Persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported herein.
    (e)
    Not applicable.
    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
     
    Standard Latitude Master has entered into cash settled total return swaps (the "Total Return Swaps") providing economic exposure to an aggregate of 1,900,000 Shares of the Issuer (representing 4.2% of the Shares of the Issuer). The Total Return Swaps provide Standard Latitude Master with economic results that are comparable to the economic results of ownership but do not provide the Reporting Persons with the power to vote or direct the voting or dispose of or direct the disposition of the shares that are referenced in the Total Return Swaps. The Total Return Swaps may only be cash settled and do not require the counterparty to the Total Return Swaps to acquire, hold, vote or dispose of any securities of the Issuer. The Reporting Persons disclaim beneficial ownership in any Shares of the Issuer that may be referenced in such Total Return Swaps or any Shares or other securities or financial instruments that may be held from time to time by the counterparty to the Total Return Swaps. The counterparty to the Total Return Swaps is an unaffiliated third party financial institution. The Reporting Persons have economic exposure to the Issuer, when such Total Return Swaps and beneficially owned shares are combined, of approximately 9.9% of the Shares outstanding. Except as set forth herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons and between such persons and any person with respect to any securities of the Issuer, including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps or any other derivative securities, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
    Item 7.Material to be Filed as Exhibits.
     
    Exhibit 99.1 - Joint Filing Agreement by and among the Reporting Persons, dated December 1, 2025.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Standard Investments LLC
     
    Signature:/s/ David S. Winter
    Name/Title:David S. Winter, Managing Member
    Date:12/01/2025
     
    Signature:/s/ David J. Millstone
    Name/Title:David J. Millstone, Managing Member
    Date:12/01/2025
     
    SI GP III LLC
     
    Signature:/s/ David S. Winter
    Name/Title:David S. Winter, Principal
    Date:12/01/2025
     
    Signature:/s/ David J. Millstone
    Name/Title:David J. Millstone, Principal
    Date:12/01/2025
     
    Standard Latitude Master Fund Ltd.
     
    Signature:/s/ David S. Winter
    Name/Title:David S. Winter, Director
    Date:12/01/2025
     
    Signature:/s/ David J. Millstone
    Name/Title:David J. Millstone, Director
    Date:12/01/2025
     
    Standard Latitude Fund LP
     
    Signature:/s/ David S. Winter
    Name/Title:David S. Winter, Principal of SI GP III LLC, its General Partner
    Date:12/01/2025
     
    Signature:/s/ David J. Millstone
    Name/Title:David J. Millstone, Principal of SI GP III LLC, its General Partner
    Date:12/01/2025
     
    David S. Winter
     
    Signature:/s/ David S. Winter
    Name/Title:David S. Winter, Individually
    Date:12/01/2025
     
    David J. Millstone
     
    Signature:/s/ David J. Millstone
    Name/Title:David J. Millstone, Individually
    Date:12/01/2025
    Get the next $ASH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASH

    DatePrice TargetRatingAnalyst
    9/8/2025$60.00Equal-Weight
    Morgan Stanley
    5/1/2025Overweight → Equal Weight
    Wells Fargo
    3/26/2025$68.00 → $71.00Neutral → Overweight
    Analyst
    3/5/2025Buy → Neutral
    Seaport Research Partners
    8/8/2024$90.00 → $89.00Underweight → Neutral
    JP Morgan
    4/11/2024$100.00 → $112.00Equal Weight → Overweight
    Wells Fargo
    3/14/2024$100.00 → $126.00Hold → Buy
    Jefferies
    3/1/2024$108.00Outperform
    Wolfe Research
    More analyst ratings

    $ASH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Ashland Inc.

    DEFA14A - ASHLAND INC. (0001674862) (Filer)

    12/9/25 4:18:03 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form DEF 14A filed by Ashland Inc.

    DEF 14A - ASHLAND INC. (0001674862) (Filer)

    12/9/25 4:15:48 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SCHEDULE 13D filed by Ashland Inc.

    SCHEDULE 13D - ASHLAND INC. (0001674862) (Subject)

    12/1/25 8:30:08 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ashland board authorizes quarterly dividend

    WILMINGTON, Del., Nov. 19, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on December 15, 2025, to stockholders of record at the close of business on December 1, 2025. As of October 31, 2025, there were 45,718,113 shares of Ashland common stock outstanding.  About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectur

    11/19/25 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026

      Sales of $478 million, down eight percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives (collectively, Portfolio Optimization) reduced overall sales by approximately $38 million or seven percent versus the prior-year quarter. Excluding these initiatives, sales declined one percentIncome from continuing operations of $33 million, or $0.73 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $50 million, or $1.08 per diluted shareNet income of $32 million, or $0.71 per diluted shareAdjusted EBITDA of $119 million, down four p

    11/4/25 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast

    WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has changed the start time of its fourth-quarter fiscal 2025 earnings webcast being held on Wednesday, November 5, 2025. The event will now begin at 10:00 a.m. ET instead of 9:00 a.m. ET.  Attendees that have previously registered do not need to register again. The company's live webcast with securities analysts will include an executive summary and detailed remarks. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. To access the call by phone, please go to this registration link and you will be provided with dial in detail

    10/30/25 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SVP and GM, Life Sciences Assis Alessandra Faccin

    4 - ASHLAND INC. (0001674862) (Issuer)

    11/21/25 4:30:22 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by SVP, CFO & PFO Whitaker William

    4 - ASHLAND INC. (0001674862) (Issuer)

    11/21/25 4:30:14 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by Chair of the Board and CEO Novo Guillermo

    4 - ASHLAND INC. (0001674862) (Issuer)

    11/21/25 4:30:18 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chair of the Board and CEO Novo Guillermo bought $2,010,327 worth of shares (31,294 units at $64.24) (SEC Form 4)

    4 - ASHLAND INC. (0001674862) (Issuer)

    2/3/25 4:30:05 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SVP and GM, Life Sciences Assis Alessandra Faccin bought $201,600 worth of shares (3,150 units at $64.00) (SEC Form 4)

    4 - ASHLAND INC. (0001674862) (Issuer)

    2/3/25 4:30:03 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Ashland with a new price target

    Morgan Stanley initiated coverage of Ashland with a rating of Equal-Weight and set a new price target of $60.00

    9/8/25 8:48:38 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland downgraded by Wells Fargo

    Wells Fargo downgraded Ashland from Overweight to Equal Weight

    5/1/25 3:02:01 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland upgraded by Analyst with a new price target

    Analyst upgraded Ashland from Neutral to Overweight and set a new price target of $71.00 from $68.00 previously

    3/26/25 7:45:24 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Leadership Updates

    Live Leadership Updates

    View All

    Ashland announces executive leadership changes

    WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan

    5/5/25 5:00:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

    Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu

    9/3/24 7:00:00 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions

    Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE:ASH) by Turnspire Capital Partners LLC ("Turnspire"). Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydratio

    9/3/24 7:00:00 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Financials

    Live finance-specific insights

    View All

    Ashland board authorizes quarterly dividend

    WILMINGTON, Del., Nov. 19, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on December 15, 2025, to stockholders of record at the close of business on December 1, 2025. As of October 31, 2025, there were 45,718,113 shares of Ashland common stock outstanding.  About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectur

    11/19/25 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026

      Sales of $478 million, down eight percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives (collectively, Portfolio Optimization) reduced overall sales by approximately $38 million or seven percent versus the prior-year quarter. Excluding these initiatives, sales declined one percentIncome from continuing operations of $33 million, or $0.73 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $50 million, or $1.08 per diluted shareNet income of $32 million, or $0.71 per diluted shareAdjusted EBITDA of $119 million, down four p

    11/4/25 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast

    WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has changed the start time of its fourth-quarter fiscal 2025 earnings webcast being held on Wednesday, November 5, 2025. The event will now begin at 10:00 a.m. ET instead of 9:00 a.m. ET.  Attendees that have previously registered do not need to register again. The company's live webcast with securities analysts will include an executive summary and detailed remarks. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. To access the call by phone, please go to this registration link and you will be provided with dial in detail

    10/30/25 5:01:00 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    $ASH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Ashland Inc.

    SC 13G - ASHLAND INC. (0001674862) (Subject)

    11/12/24 11:54:03 AM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Ashland Inc.

    SC 13G/A - ASHLAND INC. (0001674862) (Subject)

    7/10/24 1:14:41 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13D/A filed by Ashland Inc. (Amendment)

    SC 13D/A - ASHLAND INC. (0001674862) (Subject)

    4/25/24 4:15:12 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary